相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer
Chengcheng Gai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Ferroptosis-driven nanotherapeutics for cancer treatment
Xinzhu Shan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy
Qingqing Guan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP+-Induced Cell Damage
Gueliz Armagan et al.
MOLECULES (2019)
Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation
Min-Kyun Song et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor
Su Myat Phyu et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2019)
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression
Junhui Yu et al.
CELL DEATH & DISEASE (2019)
MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling
Annie Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Ling-Chu Chang et al.
CANCER LETTERS (2018)
Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
Pablo Ranea-Robles et al.
EMBO MOLECULAR MEDICINE (2018)
Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy.
Antonio Cuadrado et al.
REDOX BIOLOGY (2018)
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Z. Fan et al.
ONCOGENESIS (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
Role of GSK3β in breast cancer susceptibility
Andres Felipe Aristizabal-Pachon et al.
CANCER BIOMARKERS (2017)
Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
W. F. Theeuwes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3
Ryosuke Shintoku et al.
CANCER SCIENCE (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion
Masaki Arioka et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth
Sung Eun Kim et al.
NATURE NANOTECHNOLOGY (2016)
Regulated necrosis: disease relevance and therapeutic opportunities
Marcus Conrad et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Therapeutic targeting of GSK3 beta enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C
Yongfang Jiang et al.
GUT (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Suppression of Glycogen Synthase Kinase 3 Activity Reduces Tumor Growth of Prostate Cancer In vivo
Qing Zhu et al.
PROSTATE (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
分享论文
